Poppenberg, Kerry E.
Chien, Aichi
Santo, Briana A.
Chaves, Lee
Veeturi, Sricharan S.
Waqas, Muhammad
Monteiro, Andre
Dmytriw, Adam A.
Burkhardt, Jan-Karl
Mokin, Maxim
Snyder, Kenneth V.
Siddiqui, Adnan H.
Tutino, Vincent M. http://orcid.org/0000-0002-1331-2551
Funding for this research was provided by:
Brain Aneurysm Foundation
NIH (R43 NS115314-01)
NIH (1R01HL152270-01)
UCLA Exploratory Research Grant
Article History
Accepted: 30 October 2022
First Online: 3 December 2022
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Human Research Institutional Review Board of the University at Buffalo (study number 030474433). Informed consent was obtained from all participants involved in the study, and the study was carried out in accordance with the approved protocols.
: No specific patient information or images are given in the article.
: The datasets used in the current study are available from the corresponding author upon reasonable request.
: KEP—None. AC—Awardee of NIH grant, 1R01HL152270-01 and a UCLA Exploratory Research Grant. BAS—None. LC—None. SSV—None. MW—None. AM–None. AAD—None. J-KB—None. MM—None. KVS—Consulting/teaching: Canon Medical Systems Corporation, Penumbra Inc., Medtronic, Jacobs Institute; co-founder: Neurovascular Diagnostics, Inc. AHS—Financial interest/investor/stock options/ownership: Adona Medical, Inc., Amnis Therapeutics, BlinkTBI, Inc., Boston Scientific Corp. (for purchase of Claret Medical), Buffalo Technology Partners, Inc., Cardinal Consultants, LLC, Cerebrotech Medical Systems, Inc., Cognition Medical, Endostream Medical, Ltd, Imperative Care, Inc., International Medical Distribution Partners, Neurovascular Diagnostics, Inc., Q’Apel Medical, Inc., Radical Catheter Technologies, Inc., Rebound Therapeutics Corp. (purchased 2019 by Integra Lifesciences, Corp.), Rist Neurovascular, Inc., Sense Diagnostics, Inc., Serenity Medical, Inc., Silk Road Medical, Spinnaker Medical, Inc., StimMed, Synchron, Three Rivers Medical, Inc., Vastrax, LLC, VICIS, Inc., Viseon, Inc.; consultant/advisory board: Amnis Therapeutics, Boston Scientific, Canon Medical Systems USA, Inc., Cerebrotech Medical Systems, Inc., Cerenovus, Corindus, Inc., Endostream Medical, Ltd, Imperative Care, Inc., Integra LifeSciences Corp., Medtronic, MicroVention, Minnetronix Neuro, Inc., Northwest University – DSMB Chair for HEAT Trial, Penumbra, Q’Apel Medical, Inc., Rapid Medical, Rebound Therapeutics Corp., Serenity Medical, Inc., Silk Road Medical, StimMed, Stryker, Three Rivers Medical, Inc., VasSol, W.L. Gore & Associates; national PI/steering committees: Cerenovus LARGE trial and ARISE II trial, Medtronic SWIFT PRIME and SWIFT DIRECT trials, MicroVention FRED Trial and CONFIDENCE study, MUSC POSITIVE trial, Penumbra 3D Separator trial, COMPASS trial, INVEST trial; research grants: co-investigator, NIH/NINDS 1R01NS091075 Virtual Intervention of Intracranial Aneurysms; role: co-principal investigator, NIH-NINDS R21 NS109575-01 Optimizing Approaches to Endovascular Therapy of Acute Ischemic Stroke. VMT—Principal investigator: National Science Foundation Award No. 1746694 and NIH NINDS award R43 NS115314-0; awardee of a Brain Aneurysm Foundation grant, a Center for Advanced Technology grant, and a Cummings Foundation grant; co-founder: Neurovascular Diagnostics, Inc., QAS.AI, Inc.
: Research reported in this publication was supported, in part, by the Brain Aneurysm Foundation (VMT) and by the National Institute of Neurological Disorders and Stroke of the NIH under award number 1 R43 NS115314-01 to Neurovascular Diagnostics, Inc. (VMT). Additional support was received from the National Heart, Lung, and Blood Institute of the NIH under award number 1R01HL152270-01 (AC) and a UCLA Exploratory Research Grant (AC).
: Conceptualization: KEP and VMT; methodology: KEP, BAS, LC, and VMT; software: KEP and VMT; validation: KEP, LC, and VMT; formal analysis: KEP, BAS, LC, SSV, and VMT; investigation: KEP, AHS, and VMT; resources: AHS and VMT; data curation: KEP, MW, AM, J-KB, MM, KVS, AHS, and VMT; writing—original draft preparation: KEP, AC, and VMT; writing—review and editing: all authors; visualization: KEP, SSV, and VMT; supervision: AHS and VMT; project administration: VMT; funding acquisition: VMT. All authors have read and agreed to the published version of the manuscript.